Prestige Brands Holdings Beats Q4 Earnings, Misses Revs - Analyst Blog


Prestige Brands Holdings, Inc. 's ( PBH ) shares were down 0.6% immediately after the company reported fourth quarter fiscal 2014 earnings. However, shares gained 0.8% in the following trading session.

The company's fourth quarter fiscal 2014 earnings of 35 cents per share, were a penny above the Zacks Consensus Estimate but a penny short of the year-ago earnings.

Fourth quarter revenues were $144.3 million, down 6.6% from the year-ago quarter. The decrease was primarily due to the impact of retailer inventory adjustments which was moderated in the quarter. Revenues missed the Zacks Consensus Estimate of $147 million.

In fiscal 2014, Prestige Brands reported earnings of $1.53 per share, beating the Zacks Consensus Estimate of $1.51 per share and the year-ago earnings of $1.50 per share.

Revenues were $601.9 million in fiscal 2014, down 3.5% year over year reflecting retailer dynamics, competitive brand returns and the lower cough/cold incidence level. Revenues missed the Zacks Consensus Estimate of $604 million.

The Quarter in Detail

In the reported quarter, the Over-the-Counter (OTC) Healthcare segment generated revenues of $122.7 million, down 8.3% from the year-ago quarter. This decline reflects lower cough/cold incidence levels, entry of competitive products and changes in retailer inventory levels.

Revenues generated by the Household Cleaning segment were $21.5 million, up 3.9% year over year.

General and administrative (G&A) expenses increased 15.3% year over year to $13.1 million.

Fiscal 2015 Guidance

Prestige Brands expects fiscal 2015 adjusted earnings per share in the range of $1.75 to $1.85. The Zacks Consensus estimate of $1.82 is within the company's guidance range. The company expects revenues to grow in the range of 15%−18%.

This growth will reflect the recent Hydralyte acquisition, the upcoming Insight acquisition and higher investment in its core brands. Although revenues are expected to remain flat or decrease 3% year over year in the first half of fiscal 2015, due to strong competition in the retail environment and tough year-over-year comparisons, the company expects revenues to increase nearly 30% in the second half of fiscal 2015, primarily due to the impact of the upcoming Insight acquisition and organic growth.

Free cash flow generation is expected to be $150 million in fiscal 2015.  

Prestige Brands carries a Zacks Rank #1 (Strong Buy). Some stocks looking equally good in the health care sector include Summer Infant, Inc. ( SUMR ), Vapor Corp. ( VPCO ) and Nutrisystem, Inc. ( NTRI ). While Summer Infant carries a Zacks Rank #1, Vapor Corp. and Nutrisystem hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

NUTRI/SYSTEM (NTRI): Free Stock Analysis Report

PRESTIGE BRANDS (PBH): Free Stock Analysis Report

SUMMER INFANT (SUMR): Free Stock Analysis Report

VAPOR CORP (VPCO): Get Free Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Business , Earnings , Stocks

Referenced Stocks: NTRI , PBH , SUMR , VPCO

More from

Related Videos



Most Active by Volume

  • $17.88 ▼ 1.38%
  • $18.51 ▼ 6.98%
  • $94.01 ▼ 1.26%
  • $121.30 ▼ 0.87%
  • $23.28 ▼ 9.17%
  • $14.20 ▼ 0.77%
  • $14.83 ▼ 1.79%
  • $46.70 ▼ 0.38%
As of 7/31/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by